This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schimmer, A. D. Articles by Reed, J. C. Search for Related Content PubMed PubMed Citation Articles by Schimmer, A. D. Articles by Reed, J. C.

Identification of Small Molecules that Sensitize Resistant Tumor Cells to Tumor Necrosis Factor-Family Death Receptors

¹ Burnham Institute for Medical Research, La Jolla, California; ² Princess Margaret Hospital, Ontario Cancer Institute; ³ The McLaughlin Centre for Molecular Medicine, Toronto, Ontario, Canada; and ⁴ The M.D. Anderson Cancer Center, Houston, Texas

Requests for reprints: John C. Reed, Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037. Phone: 858-646-3140; Fax: 858-646-3194; E-mail: reedoffice{at}burnham.org.

Two major pathways for apoptosis have been identified, involving either mitochondria (intrinsic) or tumor necrosis factor (TNF)-family death receptors (extrinsic) as initiators of caspase protease activation and cell death. Because tumor resistance to TNF-family death receptor ligands is a common problem, helping malignant cells evade host immune defenses, we sought to identify compounds that selectively sensitize resistant tumor cells to death receptor ligands. We screened a 50,000-compound library for agents that enhanced anti-FAS antibody–mediated killing of FAS-resistant PPC-1 prostate cancer cell, then did additional analysis of the resulting hits to arrive at eight compounds that selectively sensitized PPC-1 cells to anti-FAS antibody (extrinsic pathway agonist) without altering sensitivity to staurosporine and etoposide (VP-16; intrinsic pathway agonists). These eight compounds did not increase Fas surface levels and also sensitized PPC-1 cells to apoptosis induced by TNF-family member TNF-related apoptosis-inducing ligand, consistent with a post-receptor mechanism. Of these, two reduced expression of c-FLIP, an intracellular antagonist of the extrinsic pathway. Characterization of the effects of the eight compounds on a panel of 10 solid tumor cell lines revealed two structurally distinct compounds that frequently sensitize to extrinsic pathway agonists. Structure-activity relation studies of one of these compounds revealed a pharmacophore from which it should be possible to generate analogues with improved potency. Altogether, these findings show the feasibility of identifying compounds that selectively enhance apoptosis via the extrinsic pathway, thus providing research tools for uncovering resistance mechanisms and a starting point for novel therapeutics aimed at restoring sensitivity of tumor cells to immune effector mechanisms. (Cancer Res 2006; 66(4): 2367-75)

This article has been cited by other articles:

				C. D. Simpson, I. A. Mawji, K. Anyiwe, M. A. Williams, X. Wang, A. L. Venugopal, M. Gronda, R. Hurren, S. Cheng, S. Serra, et al. Inhibition of the Sodium Potassium Adenosine Triphosphatase Pump Sensitizes Cancer Cells to Anoikis and Prevents Distant Tumor Formation Cancer Res., April 1, 2009; 69(7): 2739 - 2747. [Abstract] [Full Text] [PDF]

				T. E. Wood, S. Dalili, C. D. Simpson, R. Hurren, X. Mao, F. S. Saiz, M. Gronda, Y. Eberhard, M. D. Minden, P. J. Bilan, et al. A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death Mol. Cancer Ther., November 1, 2008; 7(11): 3546 - 3555. [Abstract] [Full Text] [PDF]

				J. C. Symes, M. Kurin, N. E. Fleshner, and J. A. Medin Fas-mediated killing of primary prostate cancer cells is increased by mitoxantrone and docetaxel Mol. Cancer Ther., September 1, 2008; 7(9): 3018 - 3028. [Abstract] [Full Text] [PDF]

				R. B. Zavareh, K. S. Lau, R. Hurren, A. Datti, D. J. Ashline, M. Gronda, P. Cheung, C. D. Simpson, W. Liu, A. R. Wasylishen, et al. Inhibition of the Sodium/Potassium ATPase Impairs N-Glycan Expression and Function Cancer Res., August 15, 2008; 68(16): 6688 - 6697. [Abstract] [Full Text] [PDF]

				W. Wrasidlo, A. Mielgo, V. A. Torres, S. Barbero, K. Stoletov, T. L. Suyama, R. L. Klemke, W. H. Gerwick, D. A. Carson, and D. G. Stupack The marine lipopeptide somocystinamide A triggers apoptosis via caspase 8 PNAS, February 19, 2008; 105(7): 2313 - 2318. [Abstract] [Full Text] [PDF]

				X. Mao, A. K. Stewart, R. Hurren, A. Datti, X. Zhu, Y. Zhu, C. Shi, K. Lee, R. Tiedemann, Y. Eberhard, et al. A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitin Blood, December 1, 2007; 110(12): 4047 - 4054. [Abstract] [Full Text] [PDF]

				I. A. Mawji, C. D. Simpson, M. Gronda, M. A. Williams, R. Hurren, C. J. Henderson, A. Datti, J. L. Wrana, and A. D. Schimmer A Chemical Screen Identifies Anisomycin as an Anoikis Sensitizer That Functions by Decreasing FLIP Protein Synthesis Cancer Res., September 1, 2007; 67(17): 8307 - 8315. [Abstract] [Full Text] [PDF]

				I. A. Mawji, C. D. Simpson, R. Hurren, M. Gronda, M. A. Williams, J. Filmus, J. Jonkman, R. S. Da Costa, B. C. Wilson, M. P. Thomas, et al. Critical Role for Fas-Associated Death Domain-Like Interleukin-1-Converting Enzyme-Like Inhibitory Protein in Anoikis Resistance and Distant Tumor Formation J Natl Cancer Inst, May 16, 2007; 99(10): 811 - 822. [Abstract] [Full Text] [PDF]

				U. Vijapurkar, W. Wang, and R. Herbst Potentiation of Kinesin Spindle Protein Inhibitor-Induced Cell Death by Modulation of Mitochondrial and Death Receptor Apoptotic Pathways Cancer Res., January 1, 2007; 67(1): 237 - 245. [Abstract] [Full Text] [PDF]

				U. Testa and R. Riccioni Deregulation of apoptosis in acute myeloid leukemia Haematologica, January 1, 2007; 92(1): 81 - 94. [Abstract] [Full Text] [PDF]